CXCR4 and melanoma: These results demonstrate that FTO inhibition enables a response to anti-PD-1 blockade in melanoma in vivo, and to IFNγ-induced killing in melanoma cells in vitro through regulating melanoma cell-intrinsic PD-1, CXCR4, and SOX10.